Medtronic (NYSE: MDT) announced today that it received CE mark for its ColonPRO fourth-generation software for AI-assisted colonoscopy.
The company has integrated its Eversense 365 implant with Sequel Med Tech’s insulin delivery system to automate the management of Type 1 diabetes.
Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes ...
Medtronic announced the first U.S. commercial cases for its Hugo soft-tissue robotic surgery system, conducted at Cleveland ...
Abstract: This tutorial provides a comprehensive overview of continuous-time analog-to-digital converters (ADCs), with a focus on the principles and architectures behind these devices. We start with ...
On February 2, 2026, Medtronic announced three new developments for the company’s 780G automated insulin-delivery (AID) system — cleared for use last year by the US FDA in type 2 diabetes (T2D) — ...
GALWAY, Ireland, Feb. 2, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and ...
A person wears the MiniMed 780G pump on the hip with the Instinct sensor on the arm. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) today announced three U.S. milestones expanding access to its ...
Abstract: In recent years, the number of patients using continuous glucose monitoring (CGM) has increased. In addition to helping patients manage their disease, CGM produces time series data that can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results